Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary

JAMA Intern Med. 2020 Apr 1;180(4):597-601. doi: 10.1001/jamainternmed.2019.7018.


This economic evaluation estimates insulin savings that would result if Medicare Part D used US Department of Veterans Affairs–negotiated prices and the Veterans Affairs formulary for patients with diabetes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / epidemiology
  • Drug Prescriptions / economics
  • Formularies as Topic
  • Humans
  • Hypoglycemic Agents / economics*
  • Insulin / economics*
  • Insurance Benefits / economics
  • Medicare Part D / economics*
  • United States / epidemiology
  • United States Department of Veterans Affairs*


  • Hypoglycemic Agents
  • Insulin